70 / 88
70
Scientific Programme /
Thursday, 22 June 2017
WFSBP 2017
THU
T26: NEUROPHYSIOLOGY
S-70
SYMPOSIUM
15:00–16:30
Auditorium 12
Current use of EEG-based techniques in psychiatry
Chair:
Martijn Arns, The Netherlands
Co-Chair: Adam Wichniak, Poland
001
Epilepsy spectrum disorders and episodic psychiat-
ric symptoms
Nash Boutros, USA
002
Results of the international multi-center iSPOT-A
study in ADHD: EEG predictors of treatment outcome
to methylphenidate
Martijn Arns, The Netherlands
003
Did the No-Go P300 component help to predict
relapse in recently detoxified alcoholic patients?
Salvatore Campanella, Belgium
004
Polysomnographic measures of sleep in psychiatry:
Implications for diagnosis and treatment
Adam Wichniak, Poland
T7: CHILDHOOD & ADOLESCENT DISORDERS:
BASIC/ CLINICAL
S-71
SYMPOSIUM
15:00–16:30
Auditorium 10
Sex-specific neuroendocrinological findings in conduct
disorder
Chair:
Sabine Herpertz, Germany
Co-Chair: Christine Freitag, Germany
001
The brain oxytocin system in intermale and female
aggression in rodents
Trynke De Jong, Germany
I. Neumann
002
Sex-specific differences in oxytocin effects on the
brain's salience circuit
Haang Jeung, Germany
003
Sex-specific differences and the effects of puberty
on emotional processing in adolescents with and with-
out conduct disorder
Kerstin Konrad, Germany
004
The role of basal and reactive steroid hormones
and neuropeptides in female conduct disorder
Christine Freitag, Germany
A. Martinelli, K. Ackermann, A. Bernhard, FemNAT-CD
study team
T6: BIPOLAR DISORDERS: BASIC/ CLINICAL
S-72
SYMPOSIUM
15:00–16:30
Auditorium 11
Socio-demographic and clinical differences between
Bipolar I and II Disorder (BP) and implications for
treatment
Chair:
Terence Ketter, USA
Co-Chair: Bernardo Dell'Osso, Italy
001
Bipolar I vs II Disorder (BP): Characterization of
socio-demographic and clinical variables in Italian and
American samples
Bernardo Dell'Osso, Italy
002
Clinical implications of predominant polarity and
polarity index in Bipolar Disorders (BP)
Eduard Vieta, Spain
003
Epidemiology and clinical correlates of suicide and
suicide attempts in Bipolar Disorders (BP)
Maurizio Pompili, Italy
004
Do we have evidence for differentiating pharma-
cological treatment of Bipolar I from Bipolar II Disorder
(BP)?
Terence Ketter, USA
T43: SCHIZOPHRENIA: BASIC/ CLINICAL
S-73
SYMPOSIUM
15:00–16:30
B3 M1-M2
Neuropathologic implication of abnormal cortico-
basal ganglia connectivity in schizophrenia
hallucination and its models
Chair:
Hiroyuki Nawa, Japan
001
Neuropathologic implication of pallidal hyper-
activity in the auditory abnormality of schizophrenia
animal models
Hiroyuki Nawa, Japan
002
The rat ketamine model of schizophrenia shows
aberrant oscillatory activity in the cortico-basal ganglia
circuit
Miguel Valencia, Spain
003
Prefrontal – Basal ganglia circuit dysfunction
associated with psychosis in schizophrenia
Jong Yoon, USA
004
Subcortical modulation in auditory processing and
auditory hallucinations
Toshikazu Ikuta, USA